NCT06596291
Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 8, 2025
Completion: Apr 30, 2027